Did You Know...
...that in the early 1940s GE engineer James Wright was charged with a task of utmost importance to the war effort: develop a cheap substitute for rubber that could be used to produce tires, gas masks and a whole host of military gear. Wright tackled the task diligently -- and wound up inventing Silly Putty.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120128770 | TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE The present invention relates to 1 or 2 C16-C18 acyl glycerol based compounds which are capable of activating G-protein coupled receptor 119 and thereby stimulate GLP-1 release. Compounds of the present invention are useful in the prophylaxis and/or treatment of metabol... | 05/24/2012 |
| 20120129933 | CERAMIDE DIMERS AND USE THEREOF AS PHARMACEUTICAL PREPARATION OR COSMETIC PREPARATION The invention relates to ceramide dimers which are constructed from two ceramide molecules which are crosslinked to each other via their lipophilic end. The ceramide molecules thereby have at least one hydrophilic group at their hydrophilic end for increasing the hydrat... | 05/24/2012 |
| 20120035250 | PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING Described herein are routes of synthesis and therapeutic uses of 1-alkyl, 2-acyl glycerol derivatives of formula I: which when administered to mammalian biological systems result in increased cellular concentrations of specific sn-2 substituted ethanolamine plasmalogens... | 02/09/2012 |
| 20120034303 | PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX A pharmaceutical formulation comprising an erosion matrix comprising one or more fumaric acid esters as well as one or more rate-controlling agents, wherein erosion of said erosion matrix permits controlled release of said fumaric acid ester(s).... | 02/09/2012 |
| 20120034274 | PHARMACEUTICAL COMPOSITION COMPRISING ONE OR MORE FUMARIC ACID ESTERS A pharmaceutical controlled release composition comprising one or more fumaric acid esters.... | 02/09/2012 |
| 20120029076 | MICRONIZED POLYMER POWDER AND COSMETIC COMPOSITION THEREOF The invention provides a micronized polymer powder compos Won for the use in personal care and cosmetics, the micronized polymer powder composition comprising at least one thermoplastic polyester based on at least one diol and at least one dicarboxylic acid selected fro... | 02/02/2012 |
| 20120029075 | COMPOSITIONS CONTAINING C1 TO C7 ORGANIC ACID MONOGLYCERIDES AND GLYCEROL, THEIR PREPARATION AND USE AS ANTIBACTERIALS AND ANTI-MOULD AGENTS Described are antibacterial and anti-mould compositions containing high amounts of C1 to C7 organic acid mono-glycerides and glycerol, their preparation and their use in animal feedstuffs.... | 02/02/2012 |
| 20120023653 | DELAYED-RELEASE SHAPED BODIES FOR USE IN TOILETS A shaped body suitable for use as acid-releasing body in toilets includes 10-95% of a lactic acid oligomer with an average degree of polymerization between 1.8 and 4. The shaped body provides for the controlled release of lactic acid, which serves to reduce or prevent t... | 02/02/2012 |
| 20120022159 | AMPHIPHILIC STAR-LIKE OR SCORPION-LIKE MACROMOLECULES, VARIOUS COMPOSITIONS AND USES THEREOF Biomedical uses of amphiphilic macromolecules include the use of such macromolecules in the form of nanoparticle formulations for the sequestration and/or removal of LDL, and for the treatment and prevention of atherosclerosis and atherosclerotic development. The invent... | 01/26/2012 |
| 20120009285 | Compositions for treating skin A personal care composition comprising: at least a first phase and a second phase wherein said first phase comprises a) an aqueous structured surfactant phase comprising STnS where n is between about 0 and about 2.5; b) ; c) a structuring system comprising i. optionally... | 01/12/2012 |
| 20120004304 | BILE SALT ADJUVANT FOR ANIMALS FOR IMPROVING FAT UTILIZATION EFFICIENCY IN THE BODIES OF ANIMALS, AND ANIMAL FEED COMPRISING SAME The present invention relates to a bile salt adjuvant for animals for improving fat utilization efficiency in the bodies of the animals, and to animal feed comprising same. More particularly, the present invention relates to a bile salt adjuvant for animals comprising s... | 01/05/2012 |
| 20110311467 | LONGWEARING, TRANSFER RESISTANT COSMETIC COMPOSITIONS HAVING A UNIQUE CREAMY TEXTURE AND FEEL The present invention is directed to a long wearing, transfer resistant cosmetic composition which is waterproof, comfortable and has a unique creamy texture and feel containing: (a) a reaction product of (i) at least one polyamine and (ii) at least one oil soluble high... | 12/22/2011 |
| 20110313039 | METHOD FOR INCREASING ENDOGENOUS PLASMALOGEN LEVELS IN MAMMALS The present invention relates generally to compounds such as alkylglycerol and alkoxyglycerol for use in increasing the endogenous level of plasmalogens in a mammal. In particular, these compounds are used for increasing the endogenous plasmalogen level to a level great... | 12/22/2011 |
| 20110312890 | ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS This invention relates to pharmaceutical compounds and nutritional supplements that are acetylated derivatives of naturally occurring amino acids and acetylated derivatives of peptides derived from naturally occurring amino acids containing hydroxyl groups. They are as ... | 12/22/2011 |
| 20110306664 | MEDICAL DIETARY COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES Medical dietary composition for treating neurodegenerative diseases such as Alzheimer, Parkinson's disease, and more preferably adrenoleukodystrophy comprising a mixture of glyceryl trioleate (GTO), glyceryl trierucate (GTE) and at least one conjugated linoleic acid as ... | 12/15/2011 |
| 20110306665 | COSMETIC PREPARATION, METHOD FOR PRODUCING SAME, COMPOSITION FOR COSMETIC PREPARATIONS, COSMETIC PREPARATION CONTAINING THE COMPOSITION FOR COSMETIC PREPARATIONS AND METHOD FOR PRODUCING SAME, AND CLEANSER FOR INDUSTRIAL USE The present invention is related to: (1) a cosmetic preparation including an emulsifying agent, 1,3-propanediol (PDO), and a PDO difatty acid ester, wherein the fatty acids constituting the PDO difatty acid ester are one or two or more types of fatty acids selected from... | 12/15/2011 |
| 20110306666 | NEW PLANT DERIVED SEED EXTRACT RICH IN ESSENTIALLY FATTY ACIDS DERIVED FROM SALVIA HISPANICA L. SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE A Salvia hispanica L. derived seed oil extract composition of matter containing from 60-88% PUFAs in a ratio of from 3.1:1-3.3:1 of ALA to LA, 4-10% of C-18 mono-unsaturated fatty acid, 1-5% of C-18 saturated fatty acid and 4-8% of C-16 saturated fatty acid in a ... | 12/15/2011 |
| 20110306663 | TRIHEPTANOIN DIET FOR ADULT POLYGLUCOSAN BODY DISEASE (APBD) TREATMENT Compositions and methods for the treatment and management of adult polyglucosan body disease (APBD) are disclosed herein. The APBD patients studied in the present invention experienced stabilization of disease progression and limited functional improvement with dietary ... | 12/15/2011 |
| 20110300082 | PARTIAL ESTERS OF A POLYGLYCEROL WITH AT LEAST ONE CARBOXYLIC ACID AND ONE POLYFUNCTIONAL CARBOXYLIC ACID, THEIR PREPARATION AND USE The present disclosure relates to specific (poly-)glycerol partial esters with at least one carboxylic acid and one polyfunctional carboxylic acid, and to the use thereof as emulsifier and to formulations comprising partial esters of the present disclosure.... | 12/08/2011 |
| 20110301238 | SEIZURE RELATED DISORDERS AND THERAPEUTIC METHODS THEREOF Methods of treating seizure disorders by administration of a therapeutically effective amount of at least one precursor of propionyl-CoA in the absence of a ketogenic diet are provided. The present invention particularly applies to administration of triglyceride oils an... | 12/08/2011 |
| 20110301237 | METHODS AND COMPOSITIONS FOR NOVEL LIQUID CRYSTAL DELIVERY SYSTEMS Methods of making a liquid crystal mixture essentially comprised of at least one fatty acid ester or fatty acid, at least one polyhydric solvent, and at least one alkali reactant. The resultant mixture includes at least one fatty acid ester or fatty acid, at least one p... | 12/08/2011 |
| 20110300236 | Method of treating impaired mitochondrial function Disclosed in certain embodiments is a pharmaceutical composition comprising a sugar; a Krebs cycle intermediate, precursor of a Krebs cycle intermediate, salt thereof, or combination thereof; and a component selected from the group consisting of an unsaturated lipid, ph... | 12/08/2011 |
| 20110293711 | Utilization of Dialkylfumarates The present invention relates to the use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets. For this... | 12/01/2011 |
| 20110281942 | Tautomycetin and Tautomycetin Analog Biosynthesis The present invention relates to tautomycetin (TTN) and analogs thereof. Also provided are methods of using TTN and analogs thereof in the treatment of various diseases relating to SHP2 function.... | 11/17/2011 |
| 20110280970 | ABSORBABLE PUTTY-LIKE IMPLANTS AND METHODS FOR THEIR USE FOR MECHANICAL HEMOSTASIS OF BONE AND FOR THE TREATMENT OF OSSEOUS DEFECTS The present invention relates to mechanically hemostatic body-absorbable compositions having a putty-like consistency comprising a finely powdered, carboxylic acid salt, a liquid block copolymer of ethylene oxide and propylene oxide, and a tocopherol.... | 11/17/2011 |
| 20110275713 | Acetylated amino acids as Anti-platelet agents, Nutritional And Vitamin Supplements This invention relates to pharmaceutical compounds and nutritional supplements that are acetylated derivatives of naturally occurring amino acids and acetylated derivatives of peptides derived from naturally occurring amino acids containing hydroxyl groups. They are as ... | 11/10/2011 |
| 20110257267 | Reducing the Risk of Pathological Effects of Traumatic Brain Injury The present disclosure provides methods and compositions for reducing the risk of pathological effects of traumatic brain injury.... | 10/20/2011 |
| 20110243893 | MARKERS FOR DETERMINATION OF PATIENT RESPONSIVENESS Compositions and methods are provided for prognostic classification of inflammatory diseases, e.g. inflammatory demyelinating disease, patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest. T... | 10/06/2011 |
| 20110245339 | PRODRUGS OF SHORT-CHAIN FATTY ACIDS AND TREATMENT METHODS Prodrugs made up of biologically-active short-chain fatty acids or derivatives thereof conjugated to neutral or cationic amino acids capable of intracellular transport by ATB0,+ are provided. The short-chain fatty acid or derivative thereof can be ... | 10/06/2011 |
| 20110243885 | Use of Genomic Testing and Ketogenic Compounds for Treatment of Reduced Cognitive Function This invention relates to methods of using genotyping to select patients for treatment with compounds capable of elevating ketone body concentrations in amounts effective to treat reduced neuronal metabolism associated with reduced neuronal metabolism, for example Alzhe... | 10/06/2011 |
| 20110243917 | COMPOSITION FOR THE PREVENTION AND TREATMENT OF ABSENCE SEIZURES COMPRISING PKC AGONIST AS AN EFFECTIVE INGREDIENT The present invention relates to a composition comprising PKC agonist as an active ingredient. More precisely, the present inventors confirmed that absence seizure specific SWD was reduced by administrating PKC agonist into an animal model. Therefore, the composition of... | 10/06/2011 |
| 20110237667 | Compositions Containing Diethanol Amine Esterquats The invention relates to compositions containing one or more compounds of the formula (1), wherein R1CO and R2CO are linear or branched saturated acyl groups independent of each other, having 18 to 24 C atoms, and A− is a counter-ion, ... | 09/29/2011 |
| 20110236447 | Oil-In-Water Cosmetics The present invention provides an oil-in-water cosmetic excellent in emulsion stability. The oil-in-water cosmetic includes (a) oil-droplet particles consisting of an oil component to be emulsified; (b) vesicle particles for stabilizing the oil-droplet particles; and (c... | 09/29/2011 |
| 20110237668 | CHOLINE SALTS OF SUCCINIC ACID FOR THE TREATMENT OF DEPRESSION, ANXIETY, SCHIZOPHRENIA, SLEEP DISORDER, AND EPILEPSY The present invention relates to compositions and methods for treatment of depression, anxiety, schizophrenia, sleep disorder, or epilepsy comprising monocholine salt of succinic acid of a formula (I) or a pharmaceutically acceptable salt thereof. Preferably, the pharma... | 09/29/2011 |
| 20110224156 | Propionic Acids, Propionic Acid Esters, and Related Compounds The invention relates to propionic acids, propionic acid esters, and related compounds, pharmaceutical compositions containing these compounds, and methods of using these compounds for the treatment of various diseases or conditions, including but not limited to disease... | 09/15/2011 |
| 20110217370 | SUBSTANCES FOR PROMOTING HEALTHY JOINT FUNCTION COMPRISING GLUCOSAMINE SULFATE, OMEGA-3 POLYUNSATURATED FATTY ACIDS OR DERIVATIVES THEREOF, AND UNDENATURED TYPE II COLLAGEN Medicaments and therapeutic compositions contain (1) at least one omega-3 polyunsaturated fatty acid, or at least one pharmaceutically acceptable omega-3 polyunsaturated fatty acid derivative or mixtures thereof, (2) glucosamine sulfate, and (3) undenatured Type II coll... | 09/08/2011 |
| 20110218242 | Polyunsaturated Fatty Acids for Treatment of Dementia and Pre-Dementia-Related Conditions Disclosed are compositions and methods for treating or preventing dementia and pre-dementia-related conditions and/or symptoms or characteristics of such conditions.... | 09/08/2011 |
| 20110218238 | COMPOUNDS, COMPOSITIONS, FORMULATIONS AND THEIR USES THEREOF A compound, composition, method of synthesizing and using the compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceu... | 09/08/2011 |
| 20110206741 | DHA Triglyceride Emulsions The present invention is directed to an emulsion comprising an emulsifier, an isotonic agent and a docosahexaenoic acid triglyceride (DHA-TG) wherein the emulsion is substantially free of eicosapentaenoic acid (EPA) and is suitable for parenteral administration.... | 08/25/2011 |
| 20110207819 | Fat Emulsion for Artificially Feeding Seriously Ill Intensive Care Patients The present invention relates to a pharmaceutical preparation for the prophylaxis and treatment of critical illness polyneuropathy (CIP) and critical illness myopathy (CIM). The invention further relates to an isotonic fat emulsion comprising at least one triglyceride t... | 08/25/2011 |
